rss
Br J Ophthalmol 1997;81:130-132 doi:10.1136/bjo.81.2.130
  • Original Article

Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide

  1. James T Rosenbaum,
  2. Jennifer Simpson,
  3. C Michael Neuwelt
  1. Oregon Health Sciences University, Casey Eye Institute, Portland, Oregon, USA
  1. J T Rosenbaum, MD, Oregon Health Sciences University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97201, USA.
  • Accepted 14 October 1996

Abstract

BACKGROUND Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy.

METHODS Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids.

RESULTS All patients recovered excellent visual acuity.

CONCLUSION Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.